Uber Stock Dips Following 116 Billion Bid for Delivery Hero Analysts See Strategic Rationale GitHubs AI Coding Edge Slips Amid Outages and Rising Competition Testing Microsofts Strategy Safepoints Potential 116 Billion Valuation Highlights Growing Interest in Florida Insurer IPO US Consumer Spending Squeeze Looms as TrumpEra Tax Rebates Wane and Fuel Costs Surge RBI Dividend Payout and Geopolitical Tensions Key Factors Shaping Indian Stock Market This Week Japan Set to Initiate Mercosur Trade Negotiations Focusing on Oil Imports and Auto Exports HWCPZ Q1 2026 Earnings EPS Slightly Above Estimates Subordinated Notes Gain 018 MRVL Q1 2026 Earnings Slight EPS Miss Despite Positive Market Response SUZ Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Favorable Pulp Market IBCP Q1 2026 Earnings Earnings Beat Expectations Amid Modest Stock Decline RRR Q1 2026 Earnings Earnings Beat Estimates as Stock Rises 332 Tri Pointe Homes Inc TPH Holds Steady Near 47 as Housing Sector Consolidates ArriVent BioPharma AVBP Eases 168 Support at 261 in Focus After Sector Headwinds Hudson Pacific Properties HPP Edges Lower as Office REIT Faces Cautious Investor Sentiment CocaCola Consolidated COKE Faces Resistance as Shares Pull Back 223 Editas Medicine Gains 337 as Gene Editing Biotech Tests Key Resistance at 29 The Rise of the MultiJob Workforce Economic Pressures Reshape Employment Ball Corporation Q1 2026 Earnings EPS Surprises to the Upside as Cost Initiatives Gain Traction Sound Point Meridian Capital Preferred Shares SPMA Edge Lower as Trading Remains RangeBound eXoZymes Inc EXOZ Surges 55 Key Levels to Watch After the Rally Calamos Strategic Total Return CSQ Consolidates Near Resistance Eyes Potential Upside Breakout Titan Machinery TITN Consolidates Near Support as Agricultural Sector Uncertainty Persists Definium Therapeutics DFTX Surges 341 as Volume Picks Up Testing Key Resistance Manhattan Associates MANH Edges Higher Near Key Resistance as Supply Chain Tech Momentum Holds Palomar Holdings PLMR Falls 442 as Support and Resistance Levels Take Center Stage Protagonist Therapeutics PTGX Hovering Near Resistance After Modest Pullback